Loading...
Loading...
shares climbed 12.41% to $10.96. FBR Capital initiated coverage on Bellerophon Therapeutics with a Outperform rating and a $23.00 price target. Cowen & Company initiated coverage on Bellerophon Therapeutics with a Outperform rating and a $21.00 price target.
Amarin Corporation plcAMRN shares rose 10.32% to $3.20 after surging 21.85% on Friday.
Kandi Technolgies Group, Inc. KNDI shares jumped 9.83% to $14.53. Kandi Tech reported FY earnings of $0.29 per share on revenue of $170.2 million.
Neuralstem, Inc. CUR shares rose 8.75% to $2.78. Neuralstem reported a FY14 loss $0.26 per share on revenue of $18.8 million.
A. Schulman, Inc. SHLM shares gained 7.56% to $45.24 after the company announced its plans to buy Citadel Plastics Holdings for $800 million.
Microvision Inc. MVIS shares jumped 7.30% to $2.94 following the announcement of $14.5 million in component orders.
Life Time Fitness, Inc. shares rose 5.06% to $70.60 after the company agreed to be purchased by affiliates of Leonard Green & Partners and TPG for $72.10 per share in cash.
CTI BioPharma Corp.CTICLoading...
Loading...
shares surged 4.65% to $2.06 after the company reported positive results in blood of Phase 2 results of pacritinib in patients with myelofibrosis.
King Digital Entertainment plcKING gained 4.03% to $15.50. Analysts at JP Morgan upgraded King Digital Entertainment from Neutral to Overweight.
Boston Scientific Corporation BSX shares gained 2.71% to $17.06 after the company received the FDA approval for WATCHMAN left atrial appendage closure device.
Salix Pharmaceuticals Ltd. SLXP shares jumped 1.53% to $172.00.
Valeant Pharmaceuticals Intl IncVRX has raised its bid for Salix Pharmaceuticals to $173 per share from $158 per share. The move counters an offer of $172.50 that
Endo International plcENDP offered last week.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsIntraday UpdateMarketsMoversConsumer DiscretionaryLeisure FacilitiesMarket GainersTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in